PMN Total Utang marang Modal ProMIS Neurosciences

PMN (promisneurosciences.com) - tandha merek perusahaan

ProMIS Neurosciences (PMN) is developing targeted antibodies against Alzheimer's disease, betting on massive deferred demand and high future returns. The business currently relies on clinical trial results and lacks a steady stream of income. This chart on GURU.Markets shows a total debt-to-equity ratio of 0.00, highlighting a capital shortage and a heavy dependence on R&D investments.

PMN Rasio Kabeh Utang marang Dana Pribadi ProMIS (27.06.2023 - 28.10.2026)

Rincian analitis perusahaan ProMIS Neurosciences

- rega lan prakiraan konsensus rega:
Rega saham ProMIS Neurosciences Inc.|PMN - Konsensus nilai wajar
- data kapitalisasi pasar:
Kapitalisasi pasar ProMIS Neurosciences|PMN - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham ProMIS Neurosciences|PMN - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku promisneurosciences.com|PMN - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal ProMIS Neurosciences|PMN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas ProMIS Neurosciences Inc.|PMN - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku ProMIS Neurosciences
Ringkesan analisis perusahaan:PMN ProMIS Neurosciences
Produk dadi ProMIS

This ratio measures the proportion of borrowed funds relative to equity, determining the degree of financial leverage and the risk of dependence on creditors. The current value of 0.00 against the backdrop of antibody clinical trial costs confirms a restrained approach to borrowing, while the debt leverage history of ProMIS Neurosciences (PMN) demonstrates resilient reserves and strict control over R&D expenditures.

Pesaing utama

JAZZ - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Cytokinetics Inc.|Total Utang marang Modal PTCT|Total Utang marang Modal SRRK (Scholar Rock Inc.)|Utang marang Ekuitas Centessa Pharmaceuticals|dyne-tx.com - Rasio Kabeh Utang marang Dana Pribadi|EWTX: Utang marang Ekuitas|RAPP - Rasio Total Utang marang Ekuitas|ALMS: Total Utang marang Modal|Total Utang marang Modal Zevra Corp|CTNM - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi LRMR|Utang marang Ekuitas Capricor Therapeutics CAPR|Rasio Utang marang Ekuitas Entrada Therapeutics Inc. (TRDA)|PTHS: Total Utang marang Modal|MNOV - Utang marang Modal|Serina Therapeutics, Inc. - Rasio Total Utang marang Ekuitas|BTAI: Total Utang marang Modal|Utang marang Ekuitas apimedsus.com APUS|AEON (AEON Biopharma, Inc.) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas NLSP (NLS Pharmaceutics Ltd.)|Utang marang Modal BNOX|Utang marang Ekuitas FSD Pharma (HUGE)|Utang marang Ekuitas RETA (reatapharma.com)